Latest news

Filter News Articles

Conditions






Topics




















MSWA-supported study focuses on needs of MND family carers

A new national study identified the need for greater emotional support at end of life for family carers of people with motor neurone disease (MND).

Read more

Global MND Day - Professor Samar Aoun.
CEO Marcus Stafford Announces Retirement

MSWA CEO will step down from his role in October after 19 years at the helm.

Read more

Marcus Stafford MSWA CEO announces retirement.
Nurses: Leading Neurological Support to the Future

Today, on International Nurses Day we celebrate the impact our nurses have on the healthcare system and neurological care.

Read more

PBAC Recommends MS Medication Ofatumumab for PBS

Ofatumumab (Kesimpta®) to be subsidised under the Pharmaceutical Benefit Scheme (PBS).

Read more

International Brain Awareness Week – MSWA’s research commitment

Today marks the start of Brain Awareness Week, a global campaign to spark interest, awareness and support for brain science.

As the leading organisation supporting Western Australians living with a neurological condition, MSWA is proud of a record contribution of $4m to neurological research this financial year making us Western Australia’s leading contributor to neurological research.

Read more

MSWA is WA’s leading contributor to neurological research

MSWA is proud to be Western Australia’s leading contributor to neurological research. This year, we are delighted to announce a new record contribution of $4m.

Read more

Chloe, MSWA Client and Prue Hart, MSWA Funded Researcher.
Ozanimod approved for PBS listing for relapsing remitting MS

Ozanimod (Zeposia®) listed on the Pharmaceutical Benefits Scheme for the treatment of relapsing remitting MS (RRMS).

Read more

Does childhood diet impact future MS?

A recently published work by MSWA funded researcher Dr Lucinda Black from Curtin University suggests that dietary intake during childhood could affect the development of MS as an adult.

Read more

Diet and MS.
MSWA builds new multipurpose facility in Albany

MSWA has begun construction of a new multipurpose $7m facility for people living with a neurological condition in Albany.

Read more

COVID-19 vaccination guidance for people living with multiple sclerosis (MS)

Professor Bill Carroll AM has provided advice regarding guidance for people living with multiple sclerosis (MS) and the COVID-19 vaccination.

Read more

COVID-19 vaccination guidance for people living with multiple sclerosis (MS).